| Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation RC Lindsley, W Saber, BG Mar, R Redd, T Wang, MD Haagenson, ... New England Journal of Medicine 376 (6), 536-547, 2017 | 715 | 2017 |
| Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma MC Pasquini, ZH Hu, K Curran, T Laetsch, F Locke, R Rouce, ... Blood advances 4 (21), 5414-5424, 2020 | 342 | 2020 |
| Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT C Cutler, B Logan, R Nakamura, L Johnston, S Choi, D Porter, WJ Hogan, ... Blood, The Journal of the American Society of Hematology 124 (8), 1372-1377, 2014 | 232 | 2014 |
| Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant … V Gupta, AK Malone, PN Hari, KW Ahn, ZH Hu, RP Gale, KK Ballen, ... Biology of Blood and Marrow Transplantation 20 (1), 89-97, 2014 | 160 | 2014 |
| Real-world evidence of axicabtagene ciloleucel for the treatment of large B cell lymphoma in the United States CA Jacobson, FL Locke, L Ma, J Asubonteng, ZH Hu, T Siddiqi, S Ahmed, ... Transplantation and cellular therapy 28 (9), 581. e1-581. e8, 2022 | 115 | 2022 |
| Post-marketing use outcomes of an anti-CD19 chimeric antigen receptor (CAR) T cell therapy, axicabtagene ciloleucel (Axi-Cel), for the treatment of large B cell lymphoma (LBCL … MC Pasquini, FL Locke, AF Herrera, T Siddiqi, A Ghobadi, KV Komanduri, ... Blood 134, 764, 2019 | 96 | 2019 |
| Tisagenlecleucel chimeric antigen receptor (CAR) T-cell therapy for adults with diffuse large B-cell lymphoma (DLBCL): real world experience from the Center for International … S Jaglowski, ZH Hu, Y Zhang, M Kamdar, M Ghosh, P Lulla, J Sasine, ... Blood 134, 766, 2019 | 94 | 2019 |
| Scoring system prognostic of outcome in patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome BC Shaffer, KW Ahn, ZH Hu, T Nishihori, AK Malone, D Valcárcel, ... Journal of Clinical Oncology 34 (16), 1864-1871, 2016 | 75 | 2016 |
| Survival following allogeneic transplant in patients with myelofibrosis K Gowin, K Ballen, KW Ahn, ZH Hu, H Ali, MO Arcasoy, R Devlin, ... Blood advances 4 (9), 1965-1973, 2020 | 72 | 2020 |
| Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19? MJ Frigault, S Nikiforow, MK Mansour, ZH Hu, MM Horowitz, ML Riches, ... Blood, The Journal of the American Society of Hematology 136 (1), 137-139, 2020 | 64 | 2020 |
| Allogeneic hematopoietic cell transplantation for adult chronic myelomonocytic leukemia HD Liu, KW Ahn, ZH Hu, M Hamadani, T Nishihori, B Wirk, A Beitinjaneh, ... Biology of blood and marrow transplantation 23 (5), 767-775, 2017 | 60 | 2017 |
| Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages S Feurstein, AM Trottier, N Estrada-Merly, M Pozsgai, K McNeely, ... Blood, The Journal of the American Society of Hematology 140 (24), 2533-2548, 2022 | 59 | 2022 |
| Comparing outcomes with bone marrow or peripheral blood stem cells as graft source for matched sibling transplants in severe aplastic anemia across different economic regions R Kumar, F Kimura, KW Ahn, ZH Hu, Y Kuwatsuka, JP Klein, M Pasquini, ... Biology of Blood and Marrow Transplantation 22 (5), 932-940, 2016 | 53 | 2016 |
| Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma B Wirk, TS Fenske, M Hamadani, MJ Zhang, ZH Hu, G Akpek, MD Aljurf, ... Biology of Blood and Marrow Transplantation 20 (7), 951-959, 2014 | 51 | 2014 |
| Relapse and disease-free survival in patients with myelodysplastic syndrome undergoing allogeneic hematopoietic cell transplantation using older matched sibling donors vs … GSG Murthy, S Kim, ZH Hu, N Estrada-Merly, MB Abid, M Aljurf, U Bacher, ... JAMA oncology 8 (3), 404-411, 2022 | 49 | 2022 |
| Hematopoietic cell transplantation outcomes in monosomal karyotype myeloid malignancies MC Pasquini, MJ Zhang, BC Medeiros, P Armand, ZH Hu, T Nishihori, ... Biology of Blood and Marrow Transplantation 22 (2), 248-257, 2016 | 48 | 2016 |
| Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia S Chhabra, KW Ahn, ZH Hu, S Jain, A Assal, J Cerny, EA Copelan, A Daly, ... Blood advances 2 (21), 2922-2936, 2018 | 44 | 2018 |
| Graft-versus-host disease after HLA-matched sibling bone marrow or peripheral blood stem cell transplantation: comparison of North American Caucasian and Japanese populations J Kanda, R Brazauskas, ZH Hu, Y Kuwatsuka, K Nagafuji, H Kanamori, ... Biology of Blood and Marrow Transplantation 22 (4), 744-751, 2016 | 44 | 2016 |
| Outcomes of allogeneic hematopoietic cell transplantation in children and young adults with chronic myeloid leukemia: a CIBMTR cohort analysis S Chaudhury, R Sparapani, ZH Hu, T Nishihori, H Abdel-Azim, A Malone, ... Biology of Blood and Marrow Transplantation 22 (6), 1056-1064, 2016 | 42 | 2016 |
| Tisagenlecleucel chimeric antigen receptor (CAR) T-cell therapy for relapsed/refractory children and young adults with acute lymphoblastic leukemia (ALL): real world experience … S Grupp, ZH Hu, Y Zhang, A Keating, MA Pulsipher, C Philips, ... Blood 134, 2619, 2019 | 37 | 2019 |
